Jul 272012
 
2 Flares Filament.io 2 Flares ×

Molly - Mason Bone Cancer StudyMolly, the second dog in the Mason Bone Cancer Study, just finished her stay at UPenn with Dr. Mason.  Her owner, Jenn, says that Molly was fairly comfortable during her stay at the hospital.  She received the L. Monocytogenes vaccine on Tuesday, July 24.  Molly’s temperature increased two degrees above normal as a result of the bacteria floating around in her system.  Jenn also said that Molly’s white blood cell count doubled, but her liver values remained normal.

Molly heads home to New Jersey today, but should return to Philadelphia in about three weeks for her second round of the vaccine. Thanks to Molly’s owner, Jenn, and Rebecca, Molly’s aunt, for the updates.  Here’s to hoping that Molly, and all the dogs in the Mason Bone Cancer Study, continue to do well and live long and happy lives!

Make sure you come back to read about Dolly, the third dog in the UPenn clinical trial!

2 Flares Twitter 0 Facebook 0 Pin It Share 0 Google+ 2 Filament.io 2 Flares ×

  4 Responses to “Molly Does Great in Mason Bone Cancer Study!”

Comments (4)
  1.  

    How is Molly now? Any updates?

  2.  

    Hi!, just wondering how Molly is doing these days. My dog is in Dr. Masons study & just had his 3 week visit after his 3 vaccine.

Leave a Reply to Kris Cancel reply

(required)

(required)

CommentLuv badge

Social Media Icons Powered by Acurax Social Profile Design Experts
Optimization WordPress Plugins & Solutions by W3 EDGE